QUINAZOLINE, 2-((2-BENZOTHIAZOLYLTHIO)METHYL)-4-METHYL-, 3-OXIDE
UNII RG58GY2G4K

Substance Identification & Data

This profile provides standardized clinical and technical data for Quinazoline, 2-((2-benzothiazolylthio)methyl)-4-methyl-, 3-oxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RG58GY2G4K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 6965-83-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RG58GY2G4K

CAS Registry Number

6965-83-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

QUINAZOLINE, 2-((2-BENZOTHIAZOLYLTHIO)METHYL)-4-METHYL-, 3-OXIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H13N3OS2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IIVRSDOBYSDZIQ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

461818

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(c(nc2c(c1C)cccc2)CSc3nc4ccccc4s3)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Quinazoline, 2-((2-benzothiazolylthio)methyl)-4-methyl-, 3-oxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.